In 2026, the focus of neurology has shifted from management to early molecular detection. The introduction of Tau-specific tracers that can penetrate the blood-brain barrier with higher efficiency has changed the trajectory of Alzheimer's research. Clinics in San Francisco and Berlin are now offering routine "molecular brain health" checks for high-risk populations, a trend that is rapidly...
Italiano 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt